ICRIS Québec

Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis.

Abdel-Baki, A., Medrano, S., Maranda, C., Ladouceur, M., Tahir, R., Stip, E., & Potvin, S. International Clinical Psychopharmacology 35(4):p 221-228, July 2020. | DOI: 10.1097/YIC.0000000000000310 CONSULTER

Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis. Lire la suite »

Understanding Steps and Challenges to Take-home Naloxone and Buprenorphine/naloxone Implementation in Québec Emergency Rooms: Suboxed Project

Talbot, A., Khemiri, R., Sako, A., Londei-Leduc, L., Robin, C., Marcotte, S., Therrien, G., Goulet, G., Beaudet-Hilman, G., Ouellette, C., Brissette, S., Martin, M., Titova, P. & Lauzon, P. Research Square, https://doi.org/10.21203/rs.3.rs-33331/v1 CONSULTER

Understanding Steps and Challenges to Take-home Naloxone and Buprenorphine/naloxone Implementation in Québec Emergency Rooms: Suboxed Project Lire la suite »

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada

Wendt, D. C., Marsan, S., Parker, D., Lizzy, K. E., Roper, J., Mushquash, C., Venner, K. L., Lam, A., Swansburg, J., Worth, N., Sorlagas, N., Quach, T., Manoukian, K., Bernett, P., & Radin, S. M. Journal of Substance Abuse Treatment, 2021-02-01, Volume 121, Article 108165 CONSULTER

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada Lire la suite »